Quick Answer
Healthcare Triangle, Inc. reported Research And Development Expense of $429.0 thousand for the year ending 2024.
- Healthcare Triangle, Inc. showed a decrease of -46.3% in Research And Development Expense from 2023 to 2024.
- This data is from Healthcare Triangle, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $550.2 thousand | Q1 2021: $757.0 thousand | Q2 2021: $813.0 thousand | Q3 2021: $2.20 million | Q1 2022: $1.07 million | Q2 2022: $646.0 thousand | Q3 2022: $1.47 million | Q1 2023: $539.0 thousand | Q2 2023: $102.0 thousand | Q3 2023: $54.0 thousand | Q1 2024: $127.0 thousand | Q2 2024: $207.0 thousand | Q3 2024: $175.0 thousand | Q1 2025: $144.0 thousand | Q2 2025: $55.0 thousand | Q3 2025: $59.0 thousand.
- Over the full 5 years of available data (2020 to 2024), Healthcare Triangle, Inc.'s Research And Development Expense has declined by 75.4%.
- Historical annual values: Fiscal year 2024: $429.0 thousand | Fiscal year 2023: $799.0 thousand | Fiscal year 2022: $5.95 million | Fiscal year 2021: $5.26 million | Fiscal year 2020: $1.74 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: